Suhail Ventures

Suhail Ventures is a Riyadh-based sector-agnostic early-stage fund backing globally ambitious founders with capital and regional network access to accelerate MENA market entry. Stage focus spans pre-seed through Series A with checks in the $250k to $1M range, and AI is a stated focus. Healthcare interest centers on digital health and healthcare AI within a broader technology mandate. The fund’s value proposition combines Saudi-market access with a network of regional operators and family offices that can translate into commercial relationships and follow-on capital. The right founder is either a Saudi-based operator building for Saudi and GCC markets, or a globally ambitious founder from the US, Europe, or Asia using Suhail as the entry point for MENA expansion, with a credible product and team that can absorb regional market entry support. The wrong founder is a deep medtech or therapeutics team, a Series A-plus company looking for institutional lead, or a hyper-local non-Saudi business without GCC expansion logic. Intro paths run through Riyadh’s tightly networked technology and family-business community including Monsha’at programs and the broader MISK ecosystem, frequent co-investors and follow-on partners including STV, Wa’ed Ventures, Hala Ventures, Impact46, Oqal, and Sanabil 500 MENA, and through Suhail’s existing portfolio CEOs and senior advisors. The fund’s distinctive value lies partly in its connections into Saudi operators and corporates, so warm intros from those networks materially accelerate diligence. In the pitch, lead with the founder story, real customer evidence, and a credible Saudi or GCC entry plan including specific anchor pilots or commercial relationships. Show clean unit economics, a defensible technical narrative including data and AI architecture if relevant, and a realistic view of MOH, SFDA, NPHIES, and Saudization implications. Be specific about how Suhail’s regional network creates commercial leverage versus alternative MENA partners. Caveats include the relatively small check size which means Suhail is rarely a sole lead at competitive rounds, the diligence speed which is faster than larger institutional Saudi funds but still requires meaningful regional pattern matching, and the reality that the fund’s sector-agnostic positioning means healthcare-specific support is less specialized than at dedicated health funds. For globally ambitious founders entering MENA, Suhail is a useful regional bridge.